Sectors
GLUE
Monte Rosa Therapeutics, Inc.
13.94
2 x 10.03
2 x 16.94
bid
ask
+
0.56
4.19%
2 @ 05:29 PM
14.00 +0.06 (0.43%)
| Ytd | -11.10% | |
| 1y | 190.42% |
13.12
day range
14.10
4.60
52 week range
25.77
| Open | 13.39 | Prev Close | 13.38 | Low | 13.12 | High | 14.10 | Mkt Cap | 1.19B |
| Vol | 1.11M | Avg Vol | 1.43M | EPS | -1.75 | P/E | N/A | Forward P/E | -7.43 |
| Beta | 1.53 | Short Ratio | 12.37 | Inst. Own | 115.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 19.60 | 200-d Avg | 18.52 | 1yr Est | 28.50 |
| Income Statement | |||
| Total Revenue | 8.97M | ||
| Revenues (USD) | 8.97M | ||
| Gross Profit | 8.97M | ||
| Operating Expenses | 58.10M | ||
| Research and Development Expense | 47.96M | ||
| Selling, General and Administrative Expense | 10.13M | ||
| Operating Income | -49.13M | ||
| Income Tax Expense | 208.00K | ||
| Net Income | -43.40M | ||
| Net Income Common Stock | -43.40M | ||
| Net Income Common Stock (USD) | -43.40M | ||
| Consolidated Income | -43.40M | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -43.19M | ||
| Earning Before Interest & Taxes (USD) | -43.19M | ||
| Weighted Average Shares | 101.48M | ||
| Weighted Average Shares Diluted | 101.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 95.04M | ||
| Cash and Equivalents (USD) | 95.04M | ||
| Investments | 531.00M | ||
| Investments Current | 531.00M | ||
| Trade and Non-Trade Receivables | 4.92M | ||
| Current Assets | 631.41M | ||
| Property, Plant & Equipment Net | 53.99M | ||
| Total Assets | 691.16M | ||
| Debt Current | 4.63M | ||
| Total Debt | 37.99M | ||
| Current Liabilities | 59.66M | ||
| Debt Non-Current | 33.36M | ||
| Total Liabilities | 203.88M | ||
| Accumulated Retained Earnings (Deficit) | -565.11M | ||
| Accumulated Other Comprehensive Income | -5.16M | ||
| Shareholders Equity | 487.28M | ||
| Shareholders Equity (USD) | 487.28M | ||
| Assets Non-Current | 59.76M | ||
| Total Debt (USD) | 37.99M | ||
| Deferred Revenue | 127.73M | ||
| Liabilities Non-Current | 144.22M | ||
| Trade and Non-Trade Payables | 7.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.91M | ||
| Net Cash Flow from Financing | 3.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -69.76M | ||
| Capital Expenditure | -4.72M | ||
| Issuance (Purchase) of Equity Shares | 3.21M | ||
| Net Cash Flow from Investing | -28.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -24.14M | ||
| Net Cash Flow from Operations | -44.11M | ||
| Share Based Compensation | 5.97M | ||